TickerFacts.

Madrigal Pharmaceuticals, Inc. (MDGL): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 5-for-4, first reflected in a filing dated 2026-05-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

22.43M
Year ended 2025-12-31
+9.4%
3-year compound annual growth
+7.7%
5-year compound annual growth
47.20M2009-12-31: 34.12M2010-12-31: 40.37M2011-12-31: 47.20M2020-12-31: 15.45M2021-12-31: 16.54M2022-12-31: 17.14M2023-12-31: 18.69M2024-12-31: 21.27M2025-12-31: 22.43M22.43M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3122.43M+5.5%2026-02-19, From 2025-01-01
2024-12-3121.27M+13.8%2026-02-19, From 2024-01-01
2023-12-3118.69M+9.0%2026-02-19, From 2023-01-01
2022-12-3117.14M+3.6%2025-02-26, From 2022-01-01
2021-12-3116.54M+7.0%2024-02-28, From 2021-01-01
2020-12-3115.45Mn/c2023-03-03, From 2020-01-01
No annual figure between 2011-12-31 and 2020-12-31.
2011-12-3147.20M+16.9%2012-02-22, From 2011-01-01
2010-12-3140.37M+18.3%2012-02-22, From 2010-01-01
2009-12-3134.12Mn/a2012-02-22, From 2009-01-01